ONEGATE Trademark

Trademark Overview

On Friday, January 15, 2021, a trademark application was filed for ONEGATE with the United States Patent and Trademark Office. The USPTO has given the ONEGATE trademark a serial number of 90468677. The federal status of this trademark filing is FIFTH EXTENSION - GRANTED as of Friday, April 12, 2024. This trademark is owned by Revitope Oncology, Inc.. The ONEGATE trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Development of pharmaceutical preparations for the treatment of cancer; development of platform technology, namely, immunotherapy platforms for manufacturing cancer therapeutics; scientific research services, namely, antibody engineering for analytical and clinical purposes
onegate

General Information

Serial Number90468677
Word MarkONEGATE
Filing DateFriday, January 15, 2021
Status734 - FIFTH EXTENSION - GRANTED
Status DateFriday, April 12, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 17, 2021

Trademark Statements

Pseudo MarkONE GATE
Goods and ServicesDevelopment of pharmaceutical preparations for the treatment of cancer; development of platform technology, namely, immunotherapy platforms for manufacturing cancer therapeutics; scientific research services, namely, antibody engineering for analytical and clinical purposes

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, April 16, 2021
Primary Code042
First Use Anywhere DateThursday, January 1, 1970
First Use In Commerce DateThursday, January 1, 1970

Trademark Owner History

Party NameRevitope Oncology, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCambridge, US 02139
Party NameRevitope Oncology, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, US 02139

Trademark Events

Event DateEvent Description
Friday, April 16, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, January 19, 2021NEW APPLICATION ENTERED
Sunday, June 20, 2021ASSIGNED TO EXAMINER
Sunday, July 11, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, July 28, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, August 17, 2021PUBLISHED FOR OPPOSITION
Tuesday, August 17, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 12, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, March 29, 2022SOU TEAS EXTENSION RECEIVED
Tuesday, March 29, 2022SOU EXTENSION 1 FILED
Tuesday, March 29, 2022SOU EXTENSION 1 GRANTED
Thursday, March 31, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, October 12, 2022SOU TEAS EXTENSION RECEIVED
Wednesday, October 12, 2022SOU EXTENSION 2 FILED
Wednesday, October 12, 2022SOU EXTENSION 2 GRANTED
Friday, October 14, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, April 11, 2023SOU EXTENSION 3 FILED
Tuesday, April 11, 2023SOU EXTENSION 3 GRANTED
Thursday, April 13, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, October 12, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, April 12, 2024SOU EXTENSION 5 FILED
Friday, April 12, 2024SOU TEAS EXTENSION RECEIVED
Friday, April 12, 2024SOU EXTENSION 5 GRANTED
Saturday, April 13, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, April 11, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, October 10, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, October 10, 2023SOU EXTENSION 4 FILED
Tuesday, October 10, 2023SOU EXTENSION 4 GRANTED

Related Keywords

onegate namely cancer development research antibody services engineering purposes clinical analytical